Репозиторий OAI—PMH
Репозиторий Российская Офтальмология Онлайн по протоколу OAI-PMH
Конференции
Офтальмологические конференции и симпозиумы
Видео
Видео докладов
| Реферат RUS | Реферат ENG | Литература | Полный текст |
| УДК: | 617.735-002 DOI: https://doi.org/10.25276/2410-1257-2020-3-68-70 |
Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю., Захарова Г.П., Иванова О.А., Жаруа А.А.
Морфогенез ретинобластомы при локальном введении цитостатиков
Национальный медицинский исследовательский центр глазных болезней им. Гельмгольца Минздрава России
Глазная клиника доктора Беликовой
1. Kaneko A, Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn. J. Clin. Oncol. 2003; 33 (12): 601-607.
2. Munier FL, Gaillard MC, Balmer A et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br. J. Ophthalmol. 2012; 96 (8): 1078-1083.
3. Ghassemi F, Shields CL. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch. Ophthalmol. 2012; 130 (10): 1268-1271.
4. Francis JH, Schaiquevich P, Buitrago E et al. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Ophthalmology. 2014; 121: 1810-1817.
5. Ghassemi F, Amoli FA. Pathological findings in enucleated eyes after intravitreal melphalan injection. Int. Ophthalmol. 2014; 34: 533-540.
6. Daniels AB, Froehler MT, Nunnally AH et al. Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach. Investigative Opthalmology & Visual Science. 2019; 60 (4): 954-964.
7. Smith SJ, Smith BD, Mohney BG. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br. J. Ophthalmol. 2014; 98 (3): 292- 297.
8. Aziz HA, Kim JW, Munier FL, Berry JL. Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity. Ocular Oncology and Pathology. 2016; 3 (1): 34-40.
9. Eagle RC, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic Observations After Intra-arterial Chemotherapy for Retinoblastoma. Arch. Ophthalmol. 2011; 129 (11): 1416-1421.
10. Biewald EM, Bornfeld N, Metz KA et al. Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy. Br. J. Ophthalmol. 2019; 10: 1-5.
11. Vajzovic LM, Murray TG, Aziz-Sultan MA et al. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch. Ophthalmol. 2010; 128 (12): 1619-1623.
12. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008; 115 (8): 1398-1404.
2. Munier FL, Gaillard MC, Balmer A et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br. J. Ophthalmol. 2012; 96 (8): 1078-1083.
3. Ghassemi F, Shields CL. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch. Ophthalmol. 2012; 130 (10): 1268-1271.
4. Francis JH, Schaiquevich P, Buitrago E et al. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Ophthalmology. 2014; 121: 1810-1817.
5. Ghassemi F, Amoli FA. Pathological findings in enucleated eyes after intravitreal melphalan injection. Int. Ophthalmol. 2014; 34: 533-540.
6. Daniels AB, Froehler MT, Nunnally AH et al. Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach. Investigative Opthalmology & Visual Science. 2019; 60 (4): 954-964.
7. Smith SJ, Smith BD, Mohney BG. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br. J. Ophthalmol. 2014; 98 (3): 292- 297.
8. Aziz HA, Kim JW, Munier FL, Berry JL. Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity. Ocular Oncology and Pathology. 2016; 3 (1): 34-40.
9. Eagle RC, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic Observations After Intra-arterial Chemotherapy for Retinoblastoma. Arch. Ophthalmol. 2011; 129 (11): 1416-1421.
10. Biewald EM, Bornfeld N, Metz KA et al. Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy. Br. J. Ophthalmol. 2019; 10: 1-5.
11. Vajzovic LM, Murray TG, Aziz-Sultan MA et al. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch. Ophthalmol. 2010; 128 (12): 1619-1623.
12. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008; 115 (8): 1398-1404.
Страница источника: 68-70
Каталог
Продукции
Организации
Офтальмологические клиники, производители и поставщики оборудования
Издания
Периодические издания
Партнеры
Проекта Российская Офтальмология Онлайн



















